Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    0.00 (0.00%)
Bid:
2,315.00
Ask:
2,320.00
Spread: 5.00 (0.216%)
Market Cap: £3.15b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

18 Dec 2023 07:00

RNS Number : 0460X
RIT Capital Partners PLC
18 December 2023
 

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

 

18 December 2023

 

30 November 2023 Net Asset Value

 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 30 November 2023 (with debt at fair value) was 2,377p per £1 ordinary share (31 October 2023: 2,362p).

 

 

November 2023 Highlights

 

Global equities and bonds advanced strongly in November, as better-than-expected inflation figures across developed markets supported the view that central banks have reached the peak of their tightening cycles. The yield on the US 10-year treasury declined -66bps from its October peak of 5.0% to end November at 4.3%, which drove the Nasdaq-100 up by +10.8%, while the S&P 500 posted its best month in over a year, up +9.1%. European stocks followed suit with the STOXX 600 up by +6.6%, while China's CSI 300 was down by -2.1%, as economic data continued to show mixed signs of recovery. The US dollar closed -3.7% lower against sterling, while gold rose by +2.6%.

 

Our portfolio posted a positive return for the month with healthy performance from our quoted equities and credit positions, while our meaningful dollar position detracted from returns.

 

·

The performance from our Quoted Equities book was driven by positive contributions from our exposure to value, healthcare and global quality equities.

·

Our Private Investments detracted modestly during the month, following Q3 valuations received for several of our larger fund holdings. As of 30 November, 86% of private funds were valued at 30 September reported valuations and 14% were held at 30 June valuations. All private direct positions are valued at 30 June. These will be updated for 31 December, consistent with our Valuation Policy, and the revised valuations will be included in our Annual Report & Accounts to be published early next year.

·

Our Uncorrelated Strategies book contributed positively during the month, led by contributions from credit strategies and gold.

·

The Board continued its active buyback programme, generating a further accretive impact on the NAV per share. In November, the Company repurchased approximately 0.2 million shares on behalf of shareholders. Year to date, the Company has repurchased approximately £160m worth of RIT's shares, locking in a ~26% return on investment on behalf of shareholders.

 

 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Tom Burns

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVQELFFXLLEFBK
Date   Source Headline
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
16th Dec 20207:00 amRNSTransaction in Own Shares
15th Dec 20207:00 amRNSTransaction in Own Shares
14th Dec 20207:00 amRNSNet Asset Value(s)
4th Dec 20205:36 pmRNSDirector/PDMR Shareholding
20th Nov 20204:04 pmRNSDirector/PDMR Shareholding
17th Nov 20205:27 pmRNSDirector/PDMR Shareholding
13th Nov 20207:00 amRNSNet Asset Value(s)
2nd Nov 20207:30 amRNSTransaction in Own Shares
30th Oct 20207:30 amRNSTransaction in Own Shares
15th Oct 20207:00 amRNSNet Asset Value(s)
15th Sep 20207:00 amRNSNet Asset Value(s)
17th Aug 20207:00 amRNSNet Asset Value(s)
4th Aug 20207:00 amRNSHalf-year Report
21st Jul 20207:00 amRNSNet Asset Value(s)
10th Jul 20205:25 pmRNSCommittee changes
18th Jun 20203:45 pmRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSNet Asset Value(s)
26th May 20205:15 pmRNSResult of AGM
18th May 20207:00 amRNSNet Asset Value(s)
7th May 20206:02 pmRNSDirector/PDMR Shareholding
30th Apr 202011:12 amRNSDisclosure of Rights Attached To Ordinary Shares
21st Apr 202010:05 amRNSNotice of AGM
17th Apr 20207:00 amRNSNet Asset Value(s)
6th Apr 20205:41 pmRNSDirector/PDMR Shareholding
1st Apr 20204:06 pmRNSDirector/PDMR Shareholding
24th Mar 20205:16 pmRNSAnnual General Meeting 2020 postponement
16th Mar 20207:00 amRNSNet Asset Value(s)
11th Mar 20203:47 pmRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSAnnual Financial Report
17th Feb 20207:00 amRNSNet Asset Value(s)
5th Feb 20207:00 amRNSNet Asset Value(s)
7th Jan 20204:19 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Dec 20197:00 amRNSIssue of Equity
16th Dec 20197:00 amRNSNet Asset Value(s)
4th Dec 20195:02 pmRNSComposition of Board Committee
15th Nov 20197:00 amRNSNet Asset Value(s)
22nd Oct 20195:10 pmRNSHolding(s) in Company
14th Oct 20197:00 amRNSNet Asset Value(s)
3rd Oct 20193:17 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Sep 201912:18 pmRNSCorrection
16th Sep 20197:00 amRNSNet Asset Value(s)
14th Aug 20197:00 amRNSNet Asset Value(s)
5th Aug 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNet Asset Value(s)
3rd Jul 20192:42 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
18th Jun 20195:04 pmRNSDirector/PDMR Shareholding
17th Jun 20194:20 pmRNSHolding(s) in Company
14th Jun 20197:00 amRNSNet Asset Value(s)
15th May 20197:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.